Title
Treatment and Management of ANCA-Associated Vasculitis
Authoring Organization
Publication Month/Year
July 8, 2021
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Infant, Older adult
Health Care Settings
Ambulatory
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Assessment and screening, Treatment, Management
Diseases/Conditions (MeSH)
D056653 - Rheumatoid Vasculitis, D056647 - Systemic Vasculitis, D056648 - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, D014657 - Vasculitis, D014890 - Granulomatosis with Polyangiitis, D013700 - Giant Cell Arteritis
Keywords
vasculitis, ANCA, Antineutrophil Cytoplasmic Antibody, polyangiitis, GCA, giant cell arteritis
Source Citation
Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot MA, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2021 Aug;73(8):1088-1105. doi: 10.1002/acr.24634. Epub 2021 Jul 8. PMID: 34235880.